prednisone has been researched along with Langerhans Cell Sarcoma in 6 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Langerhans Cell Sarcoma: Rare malignant neoplasm of dendritic LANGERHANS CELLS exhibiting atypical cytology, frequent mitoses, and aggressive clinical behavior. They can be distinguished from other histiocytic and dendritic proliferations by immunohistochemical and ultrastructure studies. Cytologically benign proliferations of Langerhans cells are called LANGERHANS CELL HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsukawa, T | 1 |
| Suto, K | 1 |
| Miyoshi, H | 1 |
| Oshimi, K | 1 |
| Ohshima, K | 1 |
| Miyagishima, T | 1 |
| Keklik, M | 1 |
| Sivgin, S | 1 |
| Kontas, O | 1 |
| Abdulrezzak, U | 1 |
| Kaynar, L | 1 |
| Cetin, M | 1 |
| Ma, X | 1 |
| Li, W | 1 |
| Du, J | 1 |
| Cai, L | 1 |
| Zhang, J | 1 |
| Mourah, S | 1 |
| Lorillon, G | 1 |
| Meignin, V | 1 |
| Vercellino, L | 1 |
| de Margerie-Mellon, C | 1 |
| Pages, C | 1 |
| Goldwirt, L | 1 |
| How-Kit, A | 1 |
| Tost, J | 1 |
| Lebbe, C | 1 |
| Tazi, A | 1 |
| Li, Y | 1 |
| Li, B | 1 |
| Tian, XY | 1 |
| Li, Z | 1 |
| Yoshimi, A | 1 |
| Kumano, K | 1 |
| Motokura, T | 1 |
| Takazawa, Y | 1 |
| Oota, S | 1 |
| Chiba, S | 1 |
| Takahashi, T | 1 |
| Fukayama, M | 1 |
| Kurokawa, M | 1 |
6 other studies available for prednisone and Langerhans Cell Sarcoma
| Article | Year |
|---|---|
Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Huma | 2018 |
Langerhans cell sarcoma of the nasopharynx: a rare case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Cytarabine; Disease Pr | 2013 |
A case of an adult Langerhans cell sarcoma.
Topics: Biopsy, Needle; Disease Progression; Drug Therapy, Combination; Etoposide; Fatal Outcome; Female; Hu | 2016 |
Dramatic transient improvement of metastatic BRAF(V600E)-mutated Langerhans cell sarcoma under treatment with dabrafenib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Cyclophosphamide; | 2015 |
Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophos | 2013 |
ESHAP therapy effective in a patient with Langerhans cell sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin | 2008 |